DTCFF
Price
$0.56
Change
+$0.01 (+1.82%)
Updated
Jun 13 closing price
Capitalization
28M
VALN
Price
$5.71
Change
-$0.10 (-1.72%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
468.64M
40 days until earnings call
Interact to see
Advertisement

DTCFF vs VALN

Header iconDTCFF vs VALN Comparison
Open Charts DTCFF vs VALNBanner chart's image
DEFENCE THERAPEUTICS
Price$0.56
Change+$0.01 (+1.82%)
Volume$2K
Capitalization28M
Valneva SE
Price$5.71
Change-$0.10 (-1.72%)
VolumeN/A
Capitalization468.64M
DTCFF vs VALN Comparison Chart in %
Loading...
DTCFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VALN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DTCFF vs. VALN commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTCFF is a Buy and VALN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (DTCFF: $0.56 vs. VALN: $5.81)
Brand notoriety: DTCFF and VALN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DTCFF: 130% vs. VALN: 15%
Market capitalization -- DTCFF: $28M vs. VALN: $468.64M
DTCFF [@Biotechnology] is valued at $28M. VALN’s [@Biotechnology] market capitalization is $468.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DTCFF’s FA Score shows that 0 FA rating(s) are green whileVALN’s FA Score has 1 green FA rating(s).

  • DTCFF’s FA Score: 0 green, 5 red.
  • VALN’s FA Score: 1 green, 4 red.
According to our system of comparison, VALN is a better buy in the long-term than DTCFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DTCFF’s TA Score shows that 5 TA indicator(s) are bullish while VALN’s TA Score has 5 bullish TA indicator(s).

  • DTCFF’s TA Score: 5 bullish, 0 bearish.
  • VALN’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, DTCFF is a better buy in the short-term than VALN.

Price Growth

DTCFF (@Biotechnology) experienced а 0.00% price change this week, while VALN (@Biotechnology) price change was +5.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.15%. For the same industry, the average monthly price growth was +33.42%, and the average quarterly price growth was +4.05%.

Reported Earning Dates

VALN is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VALN($469M) has a higher market cap than DTCFF($28M). DTCFF YTD gains are higher at: 43.527 vs. VALN (32.891). DTCFF has higher annual earnings (EBITDA): -3.16M vs. VALN (-55.24M). VALN has more cash in the bank: 153M vs. DTCFF (2.08M). DTCFF has less debt than VALN: DTCFF (1.39M) vs VALN (211M). VALN has higher revenues than DTCFF: VALN (186M) vs DTCFF (0).
DTCFFVALNDTCFF / VALN
Capitalization28M469M6%
EBITDA-3.16M-55.24M6%
Gain YTD43.52732.891132%
P/E RatioN/AN/A-
Revenue0186M-
Total Cash2.08M153M1%
Total Debt1.39M211M1%
TECHNICAL ANALYSIS
Technical Analysis
DTCFFVALN
RSI
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
73%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
DTCFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VALN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CLRYX21.15N/A
N/A
Columbia Large Cap Growth Opp Inst3
NBSMX48.32N/A
N/A
Neuberger Berman Small Cap Growth Instl
SVFFX76.69N/A
N/A
Smead Value I1
LFGAX38.58N/A
N/A
Lord Abbett Focused Growth A
MSCUX12.13N/A
N/A
Morgan Stanley American Resilience A

DTCFF and

Correlation & Price change

A.I.dvisor tells us that DTCFF and VERA have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DTCFF and VERA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DTCFF
1D Price
Change %
DTCFF100%
N/A
VERA - DTCFF
14%
Poorly correlated
+2.83%
BRNS - DTCFF
11%
Poorly correlated
+5.11%
MOLN - DTCFF
7%
Poorly correlated
+1.35%
VALN - DTCFF
6%
Poorly correlated
+1.57%
LYEL - DTCFF
5%
Poorly correlated
-0.27%
More

VALN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VALN has been loosely correlated with INRLF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VALN jumps, then INRLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VALN
1D Price
Change %
VALN100%
+1.57%
INRLF - VALN
42%
Loosely correlated
N/A
BMRN - VALN
35%
Loosely correlated
+1.74%
PTCT - VALN
32%
Poorly correlated
+1.09%
IPHA - VALN
32%
Poorly correlated
-1.36%
IMTX - VALN
31%
Poorly correlated
+0.90%
More